BioSpecifics Technologies Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.72 |
Market Cap |
$438.68 M |
Shares Outstanding |
7.29 M |
Public Float |
5.34 M |
Address |
35 Wilbur Street Lynbrook New York 11563 United States |
Employees | - |
Website | http://www.biospecifics.com |
Updated | 07/08/2019 |
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY. |